Sumitomo Pharma Co Ltd, formerly Sumitomo Dainippon Pharma Co Ltd, is a Japan-based pharmaceutical company. The Company operates its business through four segments. The Japan segment is engaged in the manufacture, purchase, and sale of ethical drugs. The North American segment is engaged in the manufacture, purchase, and sale of ethical drugs and conducts research and development in the areas of oncology, urology, respiratory disease, and regenerative cell medicine. The China segment is engaged in the manufacture (small packaged products) and sale of ethical pharmaceuticals. The Overseas Others segment is engaged in the manufacture and sale of ethical pharmaceuticals in Europe. The segment also purchase and sell ethical pharmaceuticals in Southeast Asia and Taiwan, as well as provide information and collection activities for the Company's products. Other business includes manufacturing, purchasing, and sales of food ingredients, food additives and chemical product materials.

• Revenue in JPY (TTM)330.31bn
• Net income in JPY-173.72bn
• Incorporated1897
• Employees6.25k

• Location
  Sumitomo Pharma Co Ltd2-6-8, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
• Phone+81 662035321
• Fax+81 662026028
• Websitehttps://www.sumitomo-pharma.co.jp/